Loading clinical trials...
Loading clinical trials...
Evaluation of the Effectiveness of a New Generation of Myopia Control Lens, Producing a Higher Myopic Control Signal Than That Produced by a Previous Generation Lens, on the Progression of Myopia in Children Aged 6 to 14 Years
Conditions
Interventions
MCL1
MCL2
Locations
1
France
Département d'Ophtalmologie, Hôpital Fondation Adolphe de Rothschild
Paris, France
Start Date
March 18, 2026
Primary Completion Date
April 1, 2028
Completion Date
May 1, 2028
Last Updated
April 23, 2026
NCT07329777
NCT06631339
NCT06692699
NCT05617794
NCT06717035
NCT03952702
Lead Sponsor
Essilor International
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions